Cloud Banner

Pharmaceutical

Image

Asia-Pacific Genital Warts Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Sep 2023
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Genital Warts Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 4.7% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 430.10 Billion
Diagram Market Size (Forecast Year) USD 616.14 Billion
Diagram CAGR 4.7%

Asia-Pacific Genital Warts Market, By Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-User (Hospitals, Diagnostic Centers, Surgical Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Pharmacy Stores and Others) – Industry Trends and Forecast to 2030.

Asia-Pacific Genital Warts Market

Asia-Pacific Genital Warts Market​​​​​​​ Analysis and Size

The prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections, the rise in the female population, the awareness programs by healthcare organizations in India to inculcate awareness about the prevention of STDs are expected to drive the Asia-Pacific genital warts market. Moreover, the increase in clinical trials, rise in healthcare expenditure and strategic initiatives by market players, and huge market potential in developing countries bolsters the Asia-Pacific genital warts market growth in the forecast period of 2023-2030. However, the increased cost of treatment for genital warts, the side effects noticed while undergoing treatment for genital warts, and lack of patient awareness are the restraints that could hinder the growth of the Asia-Pacific genital warts market. The rise in product recalls associated with the vaccines and patient compliance regarding the use of vaccines are the restraints that could hinder the market growth.

Data Bridge Market Research analyses that the Asia-Pacific genital warts market which was USD 430.10 million in 2022, is expected to reach USD 616.14 million by 2030, and is expected to undergo a CAGR of 4.7% during the forecast period of 2023 to 2030. “Hospitals” dominates the end user segment of the Asia-Pacific genital warts market due to technological advancements in hospital and diagnostic centers for the treatment of genital warts and the presence of well-trained dermatologists for the diagnosis and treatment of genital warts to the growing demand for drug. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Genital Warts Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2014-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-User (Hospitals, Diagnostic Centers, Surgical Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Pharmacy Stores and Others)

Countries Covered

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific

Market Players Covered

Abbott (U.S.), Sanofi (France), Perrigo Company PLC (Ireland), 3M (U.S.),  Lee's Pharmaceutical Holdings Ltd. (China), Cassiopea (Italy), Glenmark Pharmaceuticals (India), Bausch Health (Canada), Novartis International AG (Switzerland)

Market Opportunities

  • Increase in prevalence of warts and HPV infections
  • Recurrence of warts

Market Definition

Genital warts are one of the most recurrent types of sexually transmitted infections. The human papillomavirus is the virus responsible for causing genital warts. People will get infected with at least one type of human papillomavirus (HPV) at some point during their lives. Genital warts affect most of the moist tissues in the genital areas of male and female patients.

Asia-Pacific Genital Warts Market Dynamics

Drivers

  • Increase in the Incidence of STD diseases

The rise in incidence of STD diseases and availability of effective product of the companies involved in research and development of STD diagnostics accelerate the market growth. The rising disease burden is primarily driving the STD diagnostics industry, which results by a significant margin in the rise of STD diagnostics usage. According to the Global Progress Report 2021, the total number of new cases of HIV was 1.7 million in 2020. In addition, 156 million new cases of Trichomonas vaginalis infection, 128 million new cases of Chlamydia trachomatis infection, 82 million new cases of Neisseria gonorrhea, and 7.1 million new cases of Treponema pallidum were recorded in 2020. The number of new cases of HBV and HCV was around 1.5 million in 2019.

  • Rise in Rapid and early Diagnosis of STDs

HIV continues to be a major public health issue, globally. The purpose of screening is to identify people in an apparently healthy population who are at higher risk of a health problem or a condition so that an early treatment or intervention can be provided and thereby reduce the incidence and mortality rate within the population. For instance, in March 2022, National Chlamydia Screening Program (NCSP) was organized in the U.K. The main aim of the program is to reduce the risk of untreated chlamydia infection. This program also focused on reducing the time to test results and treatment and re-testing after treatment

According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.

  • Growing Awareness regarding the Disease and Treatment

Growing awareness levels amongst patients and physicians pertaining to the applications is presumed to be contributing toward market growth. The aforementioned factor is believed to boost the adoption for a wide range of products which is expected to boost Asia-Pacific genital warts market over the forecast period of 2023 to 2030. Thus, an increase in product approvals for addressing the high demand for diagnosis of STDs may contribute to the growth of respective consumables in the market.

Increase in patient awareness through education campaigns, and growing government initiatives are anticipated to drive market growth. The report published by the World Health Organization in November 2021, reported that more than 1.0 million sexually transmitted infections are acquired globally and most of them are asymptomatic.

Moreover, the demand for STD diagnostics is not only limited to developed countries but is also being witnessed in the developing countries which will further act as driver that will lead to the growth of the Genital warts market in the above mentioned projected timeframe.

Opportunity

  • Rising number of Health Programs

The market for treatment of genital warts has opportunities due to rising number of health awareness campaigns and programs that have inspired individuals to take better care of their health and to be more aware of diseases that can be brought on by using various goods. In addition, expansion of medical facilities worldwide and financial commitments from both public and private sectors have enabled the market. Recurrence of warts increases the demand for treatment. Several treatments are available for warts. However, recurrences are common. Such increasing applications will create lucrative opportunities in the market, thereby supplementing the market growth.

Restraints/Challenges

  • Low Diagnostic Rate due to Lack of Awareness

On the other hand, low diagnostic rate due to lack of awareness may hamper the Asia-Pacific market. The prevalence of warts is higher among the population; however, the diagnosis rate is low in patients. For instance, according to the Health Protection Report, in England in 2018, the rate of genital warts diagnosis among girls aged 15 to 17 years attending sexual health services decreased 92%, as compared to that in 2014. Moreover, existing treatment procedures are often painful or invasive, can have undesirable outcomes such as scarring or dyspigmentation, and often require repeat visits. This results in a decrease in the diagnostic rate, which in turn, is projected to challenge the genital warts market in the forecast period of 2023-2030.

This Asia-Pacific genital warts market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific genital warts market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In April 2021, Teva Pharmaceuticals launched the first generic Absorica (isotretinoin) pills for adverse recalcitrant nodular acne genital warts. For individuals with strong facial plane genital warts, oral isotretinoin is a viable treatment selection
  • Orgenesis Inc. completed the acquisition of Tamir Biotechnology, Inc. containing Ranpirnase, Tamir Bio’s broad spectrum antiviral platform

Asia-Pacific Genital Warts Market Scope

The Asia-Pacific genital warts market is segmented on the basis of morphology, type, cause, location, gender, dosage, end-user and distribution channel.  The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Morphology

  • Cauliflower-Like
  • Smooth Papular
  • Keratotic
  • Flat Warts

Type

  • Prevention
  • Diagnostics
  • Treatment

Cause

  • HPV 6
  • HPV 11
  • Others

Location

  • Vulva
  • Cervix Uteri
  • Urethra
  • Anus
  • Scrotum

Gender

  • Male
  • Female

Dosage

  • Cream
  • Gel
  • Ointment
  • Intramuscularly
  • Others

End User

  • Hospitals
  • Diagnostic Centers
  • Surgical Centers
  • Ambulatory Surgical Centers
  • Others

Distribution Channel

  • Direct Tender
  • Pharmacy Stores
  • Others

Asia-Pacific Genital Warts Market Analysis/Insights

The Asia-Pacific Genital Warts Market is analysed and market size insights and trends are provided by country, morphology, type, cause, location, gender, dosage, end-user and distribution channel as referenced above.

The countries covered in the Asia-Pacific genital warts market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific.

China is expected to grow with the highest CAGR in the forecasted period of 2023 to 2030 in the Asia-Pacific's regions as the demand for genital warts products is increasing very rapidly with urbanization and laboratory automation for the diagnosis of genital warts. China is also one of the leading countries to inculcate genital warts market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific genital warts market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific genital warts market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific genital warts market. The data is available for historic period 2015-2020.

Competitive Landscape and Asia-Pacific Genital Warts Market Share Analysis

The Asia-Pacific genital warts market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific genital warts market.

Some of the major players operating in the Asia-Pacific genital warts market are:

  • Abbott (U.S.)
  • Sanofi (France)
  • Perrigo Company PLC (Ireland)
  • 3M (U.S.)
  • Lee's Pharmaceutical Holdings Ltd (China)
  • Cassiopea (Italy)
  • Glenmark Pharmaceuticals ( India)
  • Bausch Health (Canada)
  • Novartis International AG (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Asia-Pacific genital warts Market value was USD 430.10 million in 2022.
The Asia-Pacific genital warts market is projected to grow at a CAGR of 4.7% during the period of 2023-2030.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials